Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-4899-1810-9_34 | DOI Listing |
Bioorg Med Chem Lett
April 1998
Research Department, Novartis Pharma AG, Basel, Switzerland.
The two geminal ethyl groups in the succinic acid moiety of CGP57698 (4-[3-(7-fluoro-2-quinolinyl-methoxy)phenyl-amino]-2,2-diethyl-4-oxo- butanoic acid) are responsible for the high in vitro and in vivo potency of this peptidoleukotriene antagonist of the quinoline type. The synthesis and structure activity relationships of CGP57698 and its analogs are described.
View Article and Find Full Text PDFAdv Exp Med Biol
June 1998
Novartis Pharma AG, Basel, Switzerland.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!